News

Lose weight without dieting and at the same time reduce blood pressure?

Gene transplantation led to partial restoration of vision in four practically blind patients with congenital eye disease. Such results were obtained by two independent teams of scientists from the USA and the UK, the New England Journal of Medicine reports.

The passing pennant is "the oldest"

Three recent changes in the chapter "The oldest inhabitant of the planet" of the Guinness Book of Records.

New hydrogel for joint prostheses and contact lenses

Genzyme and Sanofi: to spite my mother-in-law, will I tear out my eye?

The American biotech company Genzyme has announced the sale of its genetic research division to Laboratory Corp. of America Holdings.

Arthritis helped to find a cure for Alzheimer's disease

Alzheimer's disease will probably be defeated with the help of arthritis. More precisely, a protein that is synthesized in cells with this disease affecting the joints.

"Smart" clothes for athletes and heart attack patients

Advanced Cell Technology specialists have developed a highly efficient process for converting embryonic stem cells into hepatocytes, allowing them to begin large-scale production for use in basic research, clinical medicine and preclinical drug testing.

Diabetes Cell therapy: another breakthrough

Tiny sensors are embedded in the fabric of such clothes, registering information about movements and indicators of vital functions of the body – breathing, heart rate, temperature of various parts of the body. The data can be analyzed remotely using the built-in GPRS transmitters.

Hemophilia can be cured by endothelial cell transplantation

Reprogrammed cells: a record of productivity and precocity

The new method gives a more than two-hundredfold increase in the efficiency of reprogramming and a reduction in the period to two weeks compared to the "old" methods using four transcription factors.

Rituximab slows down the development of multiple sclerosis

Sick, wake up! It's time to take a sleeping pill!

Thanks to the microchips that are implanted into each tablet, the receiver tracks each intake of the drug. If the patient has not taken the medicine at the time set by the doctor, the receiver sends him a text message with a reminder.

A small but proud Russian biotechnology

Currently, our country is at the most important stage of making a strategic decision: how to bring the domestic bioindustry from an outsider position in the conditions of the global biotech boom.

The artificial heart is working!

The grown hearts were transplanted into the abdominal cavity of stem cell donor rats. The organs took root, and, as expected, did not cause a rejection reaction. Now it is necessary to check whether the resulting heart muscle is capable of providing sufficient blood circulation throughout the body.

Resistance of liver cells to insulin is the cause of metabolic syndrome

Are you treating periodontal disease? Check the heart!

The increased risk of periodontal disease and coronary heart disease is due to a certain section of the antisense DNA chain on the ninth chromosome.

"The formula of diseases"

In the future, the authors believe, the schemes they have created will be used in everyday medical practice: for example, during an examination, a doctor will be able to obtain information about all the patient's diseases, related diseases and – in the future – a set of genes responsible for their development.

Google has created a venture fund

The fund was named Google Ventures and will search for startups working in the field of software, e-commerce, clean technologies, biotechnology and healthcare.

RUSNANO invites banks to cooperate

RUSNANO has developed a procedure for attracting banks to provide settlement and cash services to Project companies.

Infertility insurance

For the first time in the world, Russian scientists have received full-fledged embryos grown from ovarian tissue cells after its removal.

Restricted access

23andMe, one of the first companies to provide access to its data for third-party applications, is ending their support.